Medtronic plc (MDT) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medtronic plc (MDT:NYSE), powered by AI.

Current Price
$81.32
P/E Ratio
22.4
Market Cap
104.5B
Sector
Healthcare
What is the Medtronic plc stock price forecast?

Medtronic plc is currently trading at $81.32. View real-time AI analysis on Alpha Lenz.

What is Medtronic plc insider trading activity?

View the latest insider trading data for Medtronic plc on Alpha Lenz.

What is Medtronic plc's P/E ratio?

Medtronic plc's P/E ratio is 22.4.

Medtronic plc

NYSE · MDT
$81.32+0.94(+1.17%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Medtronic plc's future dividend policy...
Alpha Chat Insight

Medtronic plc trades at a P/E of 22.4 (fair value) with solid ROE of 9.5%.

Ask for details

Company Overview

Medtronic plc is a leading global healthcare technology company that designs, manufactures, and sells innovative medical devices and therapies used in various medical procedures. The primary function of Medtronic is to improve healthcare outcomes by providing advanced therapeutic solutions. Its extensive product portfolio includes cardiac and vascular devices, diabetes-related products, minimally invasive therapies, and neurosurgical technologies. Medtronic plays a vital role in the medical device industry, catering to cardiovascular treatment, advanced diabetes management, spinal and musculoskeletal therapy, and more. Notably, the company is renowned for its pacemaker technology and is a pivotal player in cardiac care. The company's innovations significantly impact the healthcare sector by enhancing the quality of life for patients worldwide and improving the effectiveness of medical treatments. As a key player in the medical device market, Medtronic is instrumental in setting industry standards and advancing medical technology through continuous research and development. Founded in 1949 and headquartered in Dublin, Ireland, Medtronic's global presence underscores its substantial contribution to the healthcare industry across various continents.

CEOMr. Geoffrey Straub Martha
SectorHealthcare
IndustryMedical Devices
Employees95,000

Company Statistics

FY 2025

Profile

$104.54BMarket Cap
$33.54BRevenue
0.00Shares Out
95,000Employees

Margins

65.32%Gross
29.23%EBITDA
19.50%Operating
16.78%Pre-Tax
13.99%Net

Valuation

22.42P/E
2.18P/B
3.12EV/Sales
13.37EV/EBITDA
20.16P/FCF

Growth (CAGR)

1.91%Rev 3Yr
3.01%Rev 5Yr
3.45%Op Inc 3Yr
4.60%Op Inc 5Yr
-2.51%Net Inc 3Yr
-0.48%Net Inc 5Yr

Returns

5.16%ROA
9.49%ROE
7.00%ROIC

Financial Health

$2.22BCash & Cash Equivalents
$41.21BNet Debt
89.99%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Medtronic plc (ticker: MDT) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 95,000 employees. Market cap is $104.5B.

The current price is $81.32 with a P/E ratio of 22.42x and P/B of 2.18x.

ROE is 9.49% and operating margin is 19.50%. Annual revenue is $33.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Medtronic plc (MDT) Stock Forecast 2026 $81.32 — Price, Financials & Analyst Targets | Alpha Lenz